Unveiling the impact of CDK8 on tumor progression: mechanisms and therapeutic strategies

• Xiaomin Yin,
• Zhilong He,
• Kun Chen,
• Kai Ouyang,
• Changxuan Yang,
• Jianjun Li,
• Hailin Tang,
• Manbo Cai

Affiliations

Xiaomin Yin

Department of Radiotherapy, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China

Zhilong He

Department of Radiotherapy, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China

Kun Chen

Department of Radiotherapy, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China

Kai Ouyang

Department of Radiotherapy, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China

Changxuan Yang

Department of Radiotherapy, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China

Jianjun Li

Department of Urological Surgical, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China

Hailin Tang

State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China

Manbo Cai

Department of Radiotherapy, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China